WIC
TEVA icon

Wood Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Wood Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$21.8M Buy
406,400
+125
+0% +$6.62K 3.27% 8
2014
Q2 		$21.3M Buy
+406,275
New +$20.8M 3.17% 11

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wood Investment Counsel's TEVA Position: Q3 2014 in Review

Wood Investment Counsel increased its Teva Pharmaceuticals (TEVA) stake by 0.03% in Q3 2014, buying an estimated $6.62K and bringing the position to 406,400 shares worth $21.8M. The position accounts for 3.27% of the portfolio, ranked #8.

Wood Investment Counsel first reported a position in TEVA in Q2 2014 and has held it in 2 quarters since. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Wood Investment Counsel held 406,400 shares of Teva Pharmaceuticals worth $21.8M as of Q3 2014.
  • Wood Investment Counsel bought 125 Teva Pharmaceuticals shares in Q3 2014, an estimated $6.62K.
  • Teva Pharmaceuticals made up 3.27% of Wood Investment Counsel's portfolio in Q3 2014, its #8 holding.
  • Wood Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2014 and has held it in 2 quarters since.
  • 773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Wood Investment Counsel's 13F filing for Q3 2014, filed 27 Oct 2014.